ask="60.00"
ask_size="100"
average_daily_volume="384724"
bid="48.60"
bid_size="400"
book_value="14.89"
change="-1.51"
change_from_200_day_moving_average="-0.86"
change_from_50_day_moving_average="-5.99"
change_from_52_week_high="-12.38"
change_From_52_week_low="20.59"
change_in_percent="-3.01%"
close="48.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.81"
eps_estimate_next_year="-3.17"
ex_dividend_date="N/A"
float_shares="23975000"
high="51.47"
high_52_weeks="60.98"
last_trade_date="1/3/2017"
last_trade_price="48.60"
last_trade_size="15775"
last_trade_time="4:00pm"
low="48.11"
low_52_weeks="28.01"
market_capitalization="1.32B"
moving_average_200_day="49.46"
moving_average_50_day="54.59"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="58.50"
open="51.07"
pe_ratio="5.43"
peg_ratio="0.37"
percent_change_from_200_day_moving_average="-1.75%"
percent_change_from_50_day_moving_average="-10.97%"
percent_change_from_52_week_high="-20.30%"
percent_change_from_52_week_low="+73.51%"
previous_close="50.11"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.37"
price_per_sales="3.53"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.50"
stock_exchange="NMS"
symbol="FPRX"
volume="382964"
weeks_range_52="28.01 - 60.98"
